Follow up Study of Crocin on Cardiac Function Protection in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy Based on Color Doppler Ultrasound Combined With Myocardial Zymogram

Active, not recruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

September 1, 2026

Study Completion Date

September 1, 2026

Conditions
Breast Cancer
Interventions
DRUG

Crocin

According to the patient's condition, tolerance level, and personal preference, the dosage of medication was selected. During chemotherapy, the total anthocyanin tablets were divided into an experimental group (experimental group 1 and experimental group 2 based on previous heart disease) and a control group (control group 1 and control group 2 based on previous heart disease), 30 cases in each group \[experimental group: taking saffron total glycoside tablets for 8 days during each chemotherapy period (starting from the day before chemotherapy), 4 tablets/time, 3 times a day; control group: not taking saffron total glycoside tablets during chemotherapy period\]

Trial Locations (1)

250013

The First Affiliated Hospital of Shandong First Medical University (Qianfoshan Hospital in Shandong Province), Jinan

All Listed Sponsors
lead

Mei Zhang

OTHER

NCT06187818 - Follow up Study of Crocin on Cardiac Function Protection in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy Based on Color Doppler Ultrasound Combined With Myocardial Zymogram | Biotech Hunter | Biotech Hunter